Skip to main content
Log in

Ledipasvir/sofosbuvir improves QOL in patients with liver fibrosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Younossi ZM, et al. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir. Journal of Hepatology : 17 Mar 2015. Available from: URL: http://doi.org/10.1016/j.jhep.2015.03.014

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ledipasvir/sofosbuvir improves QOL in patients with liver fibrosis. PharmacoEcon Outcomes News 725, 21 (2015). https://doi.org/10.1007/s40274-015-2035-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2035-8

Navigation